Tuesday, June 24, 2025

Genpact Recognized as a Leader in Life Sciences Regulatory and Medical Affairs in 2024 Everest Group PEAK Matrix® Assessment

Related stories

Digital Science launches AI writing tools for Overleaf users

Digital Science announced the launch of AI Assist, an...

Centific and Virtue AI team up on responsible AI by Design

This integration delivers 30x faster multimodal protection enabling full-stack...

Vultr Gets $329M to Expand Global AI and Cloud Platform

Vultr secures $329M in credit financing to boost global...

Okta Adds Cross App Access to Secure enterprise AI Agents

Okta launches Cross App Access, a new OAuth-based protocol...

SWARM Biotactics Raises €13M to Advance Bio-Robotics

SWARM Biotactics, developer of bio-robotic systems based on fully...
spot_imgspot_img

Ranking highlights Genpact’s outstanding global delivery and AI capabilities, including advanced digital and AI solutions across regulatory and medical affairs value chain

Genpact, a global professional services and solutions firm delivering outcomes that shape the future, has been recognized as a Leader in the Everest Group Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® assessment for 2024.

As stated in the Everest Group report, Genpact earned this distinction due to its comprehensive suite of digital solutions, strategic partnerships with companies such as AWS and Veeva, and cutting-edge AI capabilities. Everest Group also highlighted notable Genpact digital and AI solutions:

  • Health Agency Q&A, which uses generative AI and Natural Language Processing (NLP) to automate responses to health authority inquiries, and

  • Marketing Authorization Supply Transfer, which enables integrated planning and tracking of regulatory and supply milestones with built-in business algorithms and regulatory intelligence.

“In today’s complex global regulatory environment, enterprises need partners to navigate regulations, drive AI innovation, and achieve speed to market, safety, and compliance,” said Sanjiv Tandon, Global Business Leader, Life Sciences, Genpact. “Being recognized as a top-three leader in life sciences underscores our commitment to delivering innovative AI solutions, supported by deep industry expertise, to our clients worldwide.”

Also Read: Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology

The report also acknowledged Genpact’s strong presence in the medical technology space, highlighting Genpact’s expertise in key opinion leader engagement and medical science liaison support, both of which ensure clients receive top-tier consultation and operational support.

“Life sciences enterprises face challenges such as navigating complex compliance systems, adapting to shifting regulations, and meeting diverse regional standards,” said Lloyd Fernandes, Life Sciences Practice Director, Everest Group. “As a result, there is increasing reliance on external service providers for deep expertise and advanced technology. Genpact is well-positioned to meet these needs, offering comprehensive services across regulatory affairs. Its ability to integrate deep domain expertise with robust digital solutions to automate regulatory tasks and enhance compliance processes is highly regarded by clients.”

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img